2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
258
Breast Neoplasms
218
Lung Neoplasms
207
Glioblastoma
202
Head and Neck Neoplasms
193
Prostatic Neoplasms
179
Squamous Cell Carcinoma of Head and Neck
171
Lymphoma
152
Rectal Neoplasms
139
Esophageal Neoplasms
125
Central Nervous System Neoplasms
122
Leukemia
111
Brain Neoplasms
107
Pancreatic Neoplasms
96
Precursor Cell Lymphoblastic Leukemia-Lymphoma
93
Gliosarcoma
87
Esophageal Squamous Cell Carcinoma
84
Sarcoma
82
Uterine Cervical Neoplasms
81
Neoplasms
81
Lymphoma, Follicular
81
Lymphoma, Large B-Cell, Diffuse
80
Lymphoma, Non-Hodgkin
75
Hodgkin Disease
74
Glioma
68
Burkitt Lymphoma
67
Colorectal Neoplasms
66
Leukemia, Lymphocytic, Chronic, B-Cell
63
Astrocytoma
63
Neoplasm Metastasis
60
Interventions
Temozolomide
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Cyclophosphamide
2
venetoclax
1
trametinib
1
toripalimab
1
tafasitamab
1
sonidegib
1
ribociclib
1
fludarabine
1
etoposide phosphate
1
camrelizumab
1
brivanib
1
apatinib
1
acalabrutinib
1
Vincristine
1
Valganciclovir
1
Thiotepa
1
Therapeutics
1
Telemedicine
1
Tamoxifen
1
Surveys and Questionnaires
1
Standard of Care
1
Rituximab
1
Radiotherapy
1
R-CHOP protocol
1
Patient Navigation
1
N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pyloric Stenosis, Hypertrophic
×
Radiotherapy
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled